Clinical Trial Update: Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating vitamin D (cholecalciferol) plus celecoxib to stimulate intratumoral immune reactivity in oral cancer; trial completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Mouth Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-12-21